Navigation Links
Novo Nordisk and Chip Ganassi Racing Team Up for 2011 IZOD IndyCar Series
Date:12/16/2010

INDIANAPOLIS and PRINCETON, N.J., Dec. 16, 2010 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, has partnered with Chip Ganassi Racing, LLC to create the Novo Nordisk Chip Ganassi Racing team for 2011 IZOD IndyCar season.

The team will sponsor a new entry in the series driven by American racecar driver Charlie Kimball. This partnership makes Kimball one of the first drivers from the 2010 Firestone Indy Lights series to move up the official "Road to Indy" with a full season sponsorship.

Kimball, 25, finished fourth in the 2010 Indy Lights season, capturing five podium (top three) finishes, including four second-place finishes. With this team, he will become the first licensed driver with type 1 diabetes in the history of the Indy Racing League to race at the highest level of the Series.

"We have sponsored Charlie for the past two seasons in the Firestone Indy Lights series and seen his development not only as a race car driver, but also as a role model to thousands of people with diabetes," said Camille Lee, Vice President of Diabetes Marketing at Novo Nordisk. "We are excited to join Chip and the entire Ganassi organization to ensure Charlie's success not only on the race track, but also with Novo Nordisk to show that diabetes does not have to get in the way of your dreams."

The creation of the new team allows Novo Nordisk to continue as Kimball's primary sponsor, with naming rights to the car, as well as other branding elements. Kimball will also continue to make appearances for Novo Nordisk throughout the country, with the award-winning Race with Insulin™ and other diabetes campaigns. Novo Nordisk has sponsored Kimball since he joined the Indy Racing League in the 2009 season.

"Many don't realize this, but we have had a relationship with Charlie for a number of years now. I have been keeping close tabs on him and his successes in racing from afar for a while now – whether he was racing in Formula
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic
2. Novo Nordisk to Invest $73m in Expansion of U.S. Manufacturing Facility
3. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
4. Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease
5. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
6. Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs
7. Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
8. Novo Nordisk Awarded Department of Veterans Affairs National Insulin Contract
9. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
10. Novo Nordisk is Changing Possibilities in Hemophilia
11. Novo Nordisk Wins Design Award for NovoTwist(TM) Needle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... by end of 2007-, EDMONTON, April 16, ... it has selected PX-866 as its next ... the,phosphatidylinositol-3-kinase (PI3 kinase)/ PTEN/AKT pathway, an,important survival ... of human cancer, including glioblastoma. Preclinical data,presented ...
... - As previously announced, primary endpoint not ... treatment with ERBITUX,-, NEW YORK, April 16, ... Squibb Company today,announced detailed results from the ... III trial - comparing ERBITUX(R),(Cetuximab) plus irinotecan ...
Cached Medicine Technology:Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 2Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... was forced to take dramatic action in order to ensure that ... the local DHB began trying to get his wife's anti-nausea drug ... provided with the drug. ,Joanne Piper says that the ... Hawke's Bay hospital refused to provide enough of the drug so ...
... which manufactures contact lens solution. But recently it was found ... After this report the Food and Drug Administration ... extensive microbiological testing conducted which would take up to one ... Bausch & Lomb stopped shipping the solution, called ReNu with ...
... Gosling donated a part of his liver to a 5-year old ... //. He further stated that he had no regrets about donating ... life at risk, adding that he would do it again, if ... of his family friends is said to have been instrumental in ...
... alert has been sounded by health authorities in Tripura, ... in neighbouring Assam //. The health department of Tripura ... prevent a malaria outbreak in Tripura. ,'We ... health department. Doctors and paramedics have fanned out to ...
... is getting all the more evident after this pathbreaking ... cause obesity in children accoding to the study. // ... on this skyrocketing trend of childhood obesity, which is perhaps ... type of food advertisments targeting children. ,Nearly 5,407 students ...
... a neurodegenerative disease. According to research by physicians at ... that having close friends // and staying in contact ... damaging effects of Alzheimer's disease. The results of the ... David A. Bennett, and his colleagues is the first ...
Cached Medicine News:Health News:46-Year-Old Canada Man Donates A Part Of His Liver To A Complete Stranger 2Health News:Rush Study Shows That Interactions with Friends and Family Prevents Damaging Effects of Alzheimer's disease 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: